Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
PRTA
PRTA
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
PRTA News
Adaptive Biotechnologies Shares Surge 9.7% Amid Strong Volume
Jun 12 2026
NASDAQ.COM
Prothena Major Shareholder Increases Stake
Jun 05 2026
Yahoo Finance
Coramitug Receives FDA Fast Track Designation for ATTR Amyloidosis
Apr 27 2026
Newsfilter
Prothena Corporation Announces Leadership Changes
Apr 10 2026
Newsfilter
Prothena Announces Clinical Updates on Parkinson's and Alzheimer's Treatments
Mar 21 2026
Newsfilter
Prothena Authorizes $100 Million Share Buyback Plan
Feb 28 2026
NASDAQ.COM
Prothena Board Approves $100 Million Share Repurchase Plan
Feb 27 2026
seekingalpha
Prothena Q4 Earnings Report Analysis
Feb 19 2026
seekingalpha
Prothena Board Member Paula Cobb Resigns to Join Manifold Bio as COO
Dec 12 2025
Newsfilter
Amazon Set to Surge by 31%? Check Out 10 Leading Analyst Predictions for Monday
Dec 01 2025
Benzinga
Novo Nordisk's Coramitug, a $100 Million Investment, Shows Potential in Lowering Heart Failure Biomarkers
Nov 12 2025
Benzinga
Prothena Showcases Phase 2 Results for Coramitug (Previously PRX004) Featured in Circulation, AHA's Official Journal
Nov 11 2025
Newsfilter
HC Wainwright & Co. Reaffirms Buy Rating for Prothena Corp and Increases Price Target to $30
Nov 07 2025
Benzinga
In-Depth Analysis of Prothena Corp Stock: Insights from Analysts (7 Ratings)
Oct 07 2025
Benzinga
Bristol Myers Squibb Secures Fast Track Designation from U.S. FDA for Prothena's BMS-986446 (PRX005), an Anti-MTBR-Tau Antibody for Alzheimer's Disease Treatment
Oct 01 2025
Newsfilter
Alibaba Set to Surge Over 12%? Check Out 10 Leading Analyst Predictions for Tuesday
Sep 02 2025
Benzinga
Show More News
